UK MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME RESEARCH COLLABORATIVE

That this House welcomes the UK Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research Collaborative; notes that estimates of the prevalence of ME/CFS range from 240,000 to 600,000 patients; further notes that research outcomes on ME/CFS have been limited and fragmented in the past; and supports the Collaborative's objectives which include promoting the need for world-class research into ME/CFS across all fields, encouraging multidisciplinary research and more researchers to participate and working collaboratively with funders, charities and researchers to increase the financial support for ME/CFS research in the UK.